Bruin Lands De Novo On Pressure Ulcer Assessment Tool
Executive Summary
US FDA has granted a de novo clearance to Bruin Biometrics’ SEM Scanner, which is the first device cleared to assess parts of a patient’s body that may be at risk for pressure ulcers.
You may also be interested in...
Full Steam Ahead On Medtech Value-Based Business Models
Federal health-care policy in the US, at least, is potentially in for a major transition, but that is not having much of an impact on the fundamental business models of medtech firms and their ever-accelerating focus on value-based and risk-sharing business models. Emphasis on value strategies was a significant medtech theme at this year's JP Morgan Healthcare Conference bonanza.
Q&A: Device Industry Attorney Talks Mass Tort Strategy, Pitfalls
Medtech Insight spoke to attorney Greg Dadika about mass tort litigation, including industry trends, how to find the right law firm, and when it’s the right time to settle a suit.
Lawmakers Press CMS To Enact MCIT Breakthrough Device Coverage Rule
The Medicare rule, which was delayed by 60 days under a broader regulatory freeze, is seen as critical to the reimbursement of innovative devices.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: